These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4061844)

  • 1. Isolation of plasma components by double antibody precipitation and filtration: application to the chromatographic determination of arbaprostil ([15R]-15-methylprostaglandin E2).
    Cox JW; Pullen RH; Royer ME
    Anal Chem; 1985 Oct; 57(12):2365-9. PubMed ID: 4061844
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of the prodrug, arbaprostil, [(15R)-15-methylprostaglandin E2], and its active, antiulcer (15S) epimer in humans after single dose oral administration.
    Cox JW; Bothwell WM; Pullen RH; Wynalda MA; Fitzpatrick FA; VanderLugt JT
    J Pharm Sci; 1986 Nov; 75(11):1107-12. PubMed ID: 3820107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of (15R)- and (15S)-15-methylprostaglandin E2 in human plasma with picogram per milliliter sensitivity by column-switching high-performance liquid chromatography.
    Pullen RH; Cox JW
    J Chromatogr; 1985 Oct; 343(2):271-83. PubMed ID: 4066871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of arbaprostil on the human non-pregnant uterus.
    Reele SB; Euler AR; Hanover CK; Lookabaugh JL
    Acta Obstet Gynecol Scand; 1985; 64(8):645-7. PubMed ID: 3914178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of urinary metabolites of arbaprostil in the rat.
    Thornburgh BA; Shaw SR; Wickrema Sinha AJ
    Eur J Drug Metab Pharmacokinet; 1986; 11(1):61-9. PubMed ID: 3720796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the synthesized prostaglandin E2-analogue arbaprostil on gastric mucosal lesions in rats.
    Sugiyama S; Kawabe Y; Kuroiwa M; Goto H; Tsukamoto Y; Ozawa T
    Arzneimittelforschung; 1989 Dec; 39(12):1571-3. PubMed ID: 2624606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid-promoted epimerization of arbaprostil, 15(R)-15-methylprostaglandin E2, elicits gastric antisecretory activities in rats.
    Takanashi H; Kawabe Y; Akima M
    Jpn J Pharmacol; 1991 Dec; 57(4):559-64. PubMed ID: 1803067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arbaprostil [15(R)-15-methyl prostaglandin E2] in a single nighttime dose of either 50 or 100 micrograms in acute duodenal ulcer.
    Euler AR; Bailey RJ; Zinny MA; Brandon ML; Rousseau B; Ferguson JP; Wood DR; Le VH
    Gastroenterology; 1989 Jul; 97(1):98-103. PubMed ID: 2656368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer.
    Euler AR; Popiela T; Tytgat GN; Kulig J; Lookabaugh JL; Phan TD; Kitt MM
    Gastroenterology; 1989 Apr; 96(4):967-71. PubMed ID: 2647578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study.
    Vantrappen G; Janssens J; Popiela T; Kulig J; Tytgat GN; Huibregtse K; Lambert R; Pauchard JP; Robert A
    Gastroenterology; 1982 Aug; 83(2):357-63. PubMed ID: 7044880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic separation of C-15-epimers of 15-methylprostaglandin E2 methyl ester and 15-methylprostaglandin E2.
    Lustgarten RK
    J Pharm Sci; 1976 Oct; 65(10):1533-5. PubMed ID: 978416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandin E2 and 15(R)15 methyl PGE2 on duodenal ulcer.
    Chen FW; Leong RS; Ng PL; Karim SM
    Singapore Med J; 1980 Jun; 21(3):596-8. PubMed ID: 7003723
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and characterization of the urinary metabolites of arbaprostil in the male dog after intravenous administration.
    Thornburgh BA; Shaw SR; Bronson GE; Sinha AJ
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):113-21. PubMed ID: 3208790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of arbaprostil in bleeding peptic ulcer.
    Lauritsen K; Laursen LS; Havelund T; Bytzer P; Rask-Madsen J
    Br Med J (Clin Res Ed); 1985 Oct; 291(6502):1093. PubMed ID: 3931810
    [No Abstract]   [Full Text] [Related]  

  • 15. Arbaprostil (15(R)-15-methyl PGE2): lack of effect on theophylline metabolism.
    Reele SB; Euler A; McEvers J; Metzler C
    Br J Clin Pharmacol; 1986 Feb; 21(2):239-41. PubMed ID: 3954940
    [No Abstract]   [Full Text] [Related]  

  • 16. Absorption, tissue distribution, and excretion of 3H-labeled arbaprostil in the male rat.
    Sinha AJ; Shaw SR; Thornburgh BA
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):171-7. PubMed ID: 4043145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of arbaprostil at multiple doses for the treatment of acute duodenal ulcer: a randomized double-blind placebo-controlled international trial.
    Euler AR; Krawiec J; Odes H; Gilat T; Garcia L; Rachmilewitz D; Gabryelewicz A; Gibinski K; Bass D; Barbara L
    Am J Gastroenterol; 1990 Feb; 85(2):145-9. PubMed ID: 2405642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial of arbaprostil in bleeding peptic ulcer.
    Langman MJ; Somerville KW
    Br Med J (Clin Res Ed); 1985 Nov; 291(6505):1351. PubMed ID: 3933664
    [No Abstract]   [Full Text] [Related]  

  • 19. Capillary gas chromatographic-mass spectrometric analysis of 15-deoxy-16-hydroxy-16-vinylprostaglandin E2.
    Cosulich DB; Perkinson NA; Batra VK
    J Pharm Sci; 1985 Jan; 74(1):76-8. PubMed ID: 3981424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arbaprostil in bleeding peptic ulcer.
    Joseph Sister
    Br Med J (Clin Res Ed); 1985 Dec; 291(6509):1648. PubMed ID: 2934110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.